Literature DB >> 12805458

Nuclear export of Vpr is required for efficient replication of human immunodeficiency virus type 1 in tissue macrophages.

Michael P Sherman1, Carlos M C de Noronha, Lauren A Eckstein, Jason Hataye, Pamela Mundt, Samuel A F Williams, Jason A Neidleman, Mark A Goldsmith, Warner C Greene.   

Abstract

Retroviruses must gain access to the host cell nucleus for subsequent replication and viral propagation. Human immunodeficiency virus type 1 (HIV-1) and other primate lentiviruses are distinguished from the gammaretroviruses by their ability to infect nondividing cells such as macrophages, an important viral reservoir in vivo. Rather than requiring nuclear membrane breakdown during cell division, the HIV-1 preintegration complex (PIC) enters the nucleus by traversing the central aqueous channel of the limiting nuclear pore complex. The HIV-1 PIC contains three nucleophilic proteins, matrix, integrase, and Vpr, all of which have been implicated in nuclear targeting. The mechanism by which Vpr can display such nucleophilic properties and yet also be available for incorporation into virions assembling at the plasma membrane is unresolved. We recently characterized Vpr as a nucleocytoplasmic shuttling protein that contains two novel nuclear import signals and an exportin-1-dependent nuclear export signal (NES). We now demonstrate that mutation of this NES impairs the incorporation of Vpr into newly formed virions. Furthermore, we find that the Vpr NES is required for efficient HIV replication in tissue macrophages present in human spleens and tonsils. These findings underscore how the nucleocytoplasmic shuttling of Vpr not only contributes to nuclear import of the HIV-1 PIC but also enables Vpr to be present in the cytoplasm for incorporation into virions, leading to enhancement of viral spread within nondividing tissue macrophages.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12805458      PMCID: PMC164827          DOI: 10.1128/jvi.77.13.7582-7589.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  80 in total

1.  CRM1 is an export receptor for leucine-rich nuclear export signals.

Authors:  M Fornerod; M Ohno; M Yoshida; I W Mattaj
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

2.  Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr.

Authors:  S Mahalingam; V Ayyavoo; M Patel; T Kieber-Emmons; D B Weiner
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

3.  Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest.

Authors:  S A Stewart; B Poon; J B Jowett; I S Chen
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition.

Authors:  M D Miller; C M Farnet; F D Bushman
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

5.  Experimental HIV infection of human lymphoid tissue: correlation of CD4+ T cell depletion and virus syncytium-inducing/non-syncytium-inducing phenotype in histocultures inoculated with laboratory strains and patient isolates of HIV type 1.

Authors:  S Glushakova; B Baibakov; J Zimmerberg; L B Margolis
Journal:  AIDS Res Hum Retroviruses       Date:  1997-04-10       Impact factor: 2.205

6.  Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA.

Authors:  B Wolff; J J Sanglier; Y Wang
Journal:  Chem Biol       Date:  1997-02

7.  Nuclear import and cell cycle arrest functions of the HIV-1 Vpr protein are encoded by two separate genes in HIV-2/SIV(SM).

Authors:  T M Fletcher; B Brichacek; N Sharova; M A Newman; G Stivahtis; P M Sharp; M Emerman; B H Hahn; M Stevenson
Journal:  EMBO J       Date:  1996-11-15       Impact factor: 11.598

8.  Human immunodeficiency virus type 1 cell cycle control: Vpr is cytostatic and mediates G2 accumulation by a mechanism which differs from DNA damage checkpoint control.

Authors:  S R Bartz; M E Rogel; M Emerman
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Recovery of replication-competent HIV despite prolonged suppression of plasma viremia.

Authors:  J K Wong; M Hezareh; H F Günthard; D V Havlir; C C Ignacio; C A Spina; D D Richman
Journal:  Science       Date:  1997-11-14       Impact factor: 47.728

10.  Role of the karyopherin pathway in human immunodeficiency virus type 1 nuclear import.

Authors:  P Gallay; V Stitt; C Mundy; M Oettinger; D Trono
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

View more
  25 in total

1.  Mechanisms and inhibition of HIV integration.

Authors:  Christophe Marchand; Allison A Johnson; Elena Semenova; Yves Pommier
Journal:  Drug Discov Today Dis Mech       Date:  2006-07-01

2.  HIV-1 Vpr protein activates the NF-κB pathway to promote G2/M cell cycle arrest.

Authors:  Zhibin Liang; Ruikang Liu; Yongquan Lin; Chen Liang; Juan Tan; Wentao Qiao
Journal:  Virol Sin       Date:  2015-12-14       Impact factor: 4.327

3.  Human immunodeficiency virus type 1 Vpr-dependent cell cycle arrest through a mitogen-activated protein kinase signal transduction pathway.

Authors:  Naoto Yoshizuka; Yuko Yoshizuka-Chadani; Vyjayanthi Krishnan; Steven L Zeichner
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 Vpr induces G2 checkpoint activation by interacting with the splicing factor SAP145.

Authors:  Yasuhiko Terada; Yuko Yasuda
Journal:  Mol Cell Biol       Date:  2006-08-21       Impact factor: 4.272

5.  Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review.

Authors:  Bryan P Irish; Zafar K Khan; Pooja Jain; Michael R Nonnemacher; Vanessa Pirrone; Saifur Rahman; Nirmala Rajagopalan; Joyce B Suchitra; Kate Mostoller; Brian Wigdahl
Journal:  Am J Infect Dis       Date:  2009-07-01

Review 6.  Defining the roles for Vpr in HIV-1-associated neuropathogenesis.

Authors:  Tony James; Michael R Nonnemacher; Brian Wigdahl; Fred C Krebs
Journal:  J Neurovirol       Date:  2016-04-07       Impact factor: 2.643

7.  HIV-1 replication through hHR23A-mediated interaction of Vpr with 26S proteasome.

Authors:  Ge Li; Robert T Elder; Larisa Dubrovsky; Dong Liang; Tatiana Pushkarsky; Karen Chiu; Tao Fan; Josephine Sire; Michael Bukrinsky; Richard Y Zhao
Journal:  PLoS One       Date:  2010-06-29       Impact factor: 3.240

Review 8.  Limelight on two HIV/SIV accessory proteins in macrophage infection: is Vpx overshadowing Vpr?

Authors:  Diana Ayinde; Claire Maudet; Catherine Transy; Florence Margottin-Goguet
Journal:  Retrovirology       Date:  2010-04-09       Impact factor: 4.602

Review 9.  HIV-1 viral protein R (Vpr) and its interactions with host cell.

Authors:  Ge Li; Michael Bukrinsky; Richard Y Zhao
Journal:  Curr HIV Res       Date:  2009-03       Impact factor: 1.581

10.  HIV-1 Vpr oligomerization but not that of Gag directs the interaction between Vpr and Gag.

Authors:  Joëlle V Fritz; Denis Dujardin; Julien Godet; Pascal Didier; Jan De Mey; Jean-Luc Darlix; Yves Mély; Hugues de Rocquigny
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.